TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8632538

Group type: EXPERIMENTAL
Intervention: 1 instillation of mitomycin C (40 mg/40 ml water)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: 5 instillations of mitomycin C (40 mg/40 ml water)
Number of subjects: 502

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 502
Study: 1626676

Group type: EXPERIMENTAL
Intervention: Epidural catheter migration
Number of subjects: 153
Study: 2860183

Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine (PVP-I)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 100
Study: 28956139

Group type: EXPERIMENTAL
Intervention: Sliced soaked almonds
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sliced unsoaked almonds
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Whole soaked almonds
Number of subjects: 76

Group type: COMPARATOR
Intervention: Whole unsoaked almonds
Number of subjects: 76
Study: 26681495

Group type: EXPERIMENTAL
Intervention: Gene loci associated with schizophrenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Variants in brain-related genes with low NSS score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candidate schizophrenia susceptibility loci
Number of subjects: 0
Study: 25518875

Group type: EXPERIMENTAL
Intervention: Routine podiatry care and a falls prevention leaflet
Number of subjects: 2600

Group type: EXPERIMENTAL
Intervention: Routine podiatry care, a falls prevention leaflet, and a multifaceted podiatry intervention
Number of subjects: 2600
Study: 21802253

Group type: EXPERIMENTAL
Intervention: Posterior approach with posterior soft tissue repair
Number of subjects: 196

Group type: COMPARATOR
Intervention: Lateral approach
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 196
Study: 20436703

Group type: EXPERIMENTAL
Intervention: Tandem high-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Single high-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR)
Number of subjects: 141
Study: 17708780

Group type: EXPERIMENTAL
Intervention: Active rTMS over left dorsolateral prefrontal cortex (DLPFC) (5 Hz rTMS; 120% motor threshold) with placebo pill
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham rTMS with fluoxetine 20 mg/d
Number of subjects: 21
Study: 18391714

Group type: EXPERIMENTAL
Intervention: Chitra-HABg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Autogenous graft
Number of subjects: 24
Study: 15209326

Group type: EXPERIMENTAL
Intervention: Fitness-and-health magazine exposure
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fashion magazine exposure
Number of subjects: 90

Group type: COMPARATOR
Intervention: News magazine exposure
Number of subjects: 90
Study: 11401114

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9431896

Group type: EXPERIMENTAL
Intervention: alpha‐IFN 2a, 3 MU, three times weekly for 12 months
Number of subjects: 90
Study: 8324675

Group type: EXPERIMENTAL
Intervention: Early appendectomy (group B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional treatment (group A)
Number of subjects: 56
Study: 2948451

Group type: EXPERIMENTAL
Intervention: Etretin therapy (50 mg/d)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Etretin therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Etretin therapy for six or more months
Number of subjects: 21
Study: 31969168

Group type: EXPERIMENTAL
Intervention: French lyophilized plasma (FLYP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 140
Study: 31573942

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and electrical somatosensory stimulation of the tongue for 12 weeks
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with different stimulation settings over 12 weeks
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with stratification for hyperacusis and high tinnitus symptom severity
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with a CE-marked device
Number of subjects: 192
Study: 28284927

Group type: EXPERIMENTAL
Intervention: Apneic oxygenation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-tidal-volume ventilation
Number of subjects: 24
Study: 25105832

Group type: EXPERIMENTAL
Intervention: Multiband (MB) gradient‐echo echo planar imaging (GE‐EPI) with two-fold slice acceleration (MB2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard GE‐EPI (MB1)
Number of subjects: 0
Study: 23683002

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 2330

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 2330
Study: 21299313

Group type: EXPERIMENTAL
Intervention: Approach training to conceptually approach Blacks
Number of subjects: 0
Study: 19815635

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122
Study: 16937281

Group type: EXPERIMENTAL
Intervention: Beating heart (off-pump)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cardiopulmonary bypass with warm cardioplegia
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cardiopulmonary bypass with cold cardioplegia
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cardiopulmonary bypass (both warm and cold)
Number of subjects: 25
Study: 15283938

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy (0.625 mg conjugated equine estrogens + 5 mg medroxyprogesterone daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy (50 microg estradiol + 5 mg medroxyprogesterone daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: All groups (Tibolone and both hormone replacement therapies)
Number of subjects: 42
Study: 11828945

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and Carboplatin AUC 7
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel 160 mg/m2 and Carboplatin AUC 6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and Carboplatin AUC 6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF)
Number of subjects: 0
Study: 9016011

Group type: EXPERIMENTAL
Intervention: Strategies to increase patient control of visiting
Number of subjects: 0
Study: 8279246

Group type: EXPERIMENTAL
Intervention: Propofol/alfentanil anaesthesia
Number of subjects: 86

Group type: COMPARATOR
Intervention: Thiopentone/halothane anaesthesia
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both anaesthesia methods
Number of subjects: 86
Study: 3033389

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg bid for 8 days on a 50 mmol sodium diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: Enalapril 10 mg bid for 8 days on a 200 mmol sodium diet
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 50 mmol sodium diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: 200 mmol sodium diet
Number of subjects: 9
Study: 31982219

Group type: EXPERIMENTAL
Intervention: Mouth to Mouth ventilation (MM-only) at 5 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mouth to Mouth ventilation (MM-only) at 10 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Full CPR at 5 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Full CPR at 10 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Quality of MM at 5 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Quality of MM at 10 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Quality of CPR at 5 kn
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Quality of CPR at 10 kn
Number of subjects: 13

Group type: COMPARATOR
Intervention: Resuscitation on RWC
Number of subjects: 13
Study: 30501828

Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation (PRP) plus intravitreal bevacizumab (IVB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone
Number of subjects: 60
Study: 27603354

Group type: EXPERIMENTAL
Intervention: Sinus tarsi approach
Number of subjects: 64

Group type: COMPARATOR
Intervention: Extended lateral approach
Number of subjects: 64
Study: 24749779

Group type: EXPERIMENTAL
Intervention: Behavioral economic measures of alcohol reward value (demand persistence and amplitude of demand)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Behavioral economic indices of reward value
Number of subjects: 207
Study: 22581278

Group type: EXPERIMENTAL
Intervention: 8-form Tai chi
Number of subjects: 101

Group type: COMPARATOR
Intervention: Education control
Number of subjects: 101
Study: 20079596

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 1800
Study: 18575157

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg, 40 mg-80 mg)
Number of subjects: 83
Study: 17477207

Group type: EXPERIMENTAL
Intervention: Choice photographs with anticipated important choice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Choice photographs with anticipated unimportant choice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice photographs with caffeine arousal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Choice photographs with informed arousal source
Number of subjects: 0

Group type: COMPARATOR
Intervention: Choice photographs with no arousal
Number of subjects: 0
Study: 11345494

Group type: EXPERIMENTAL
Intervention: Curved cane
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional straight long cane
Number of subjects: 18
Study: 9848888

Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg BID for 12 weeks
Number of subjects: 189
Study: 8055741

Group type: EXPERIMENTAL
Intervention: 0.56 g/kg alcohol
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 3180108

Group type: EXPERIMENTAL
Intervention: 30 mg dexfenfluramine (d‐FF)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 4 mg metergoline (MTG)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: d‐FF
Number of subjects: 13
Study: 31879276

Group type: EXPERIMENTAL
Intervention: Salud al Día intervention (educational video and interactive text messages)
Number of subjects: 157
Study: 29253560

Group type: EXPERIMENTAL
Intervention: 4CMenB vaccination (reduced 2 + 1 or licensed 3 + 1 schedule)
Number of subjects: 851

Group type: EXPERIMENTAL
Intervention: Additional 4CMenB dose in follow-on participants
Number of subjects: 851

Group type: EXPERIMENTAL
Intervention: 2 catch-up doses in vaccine-naïve participants
Number of subjects: 851

Group type: COMPARATOR
Intervention: 4CMenB vaccination (2 + 1 or 3 + 1 schedule)
Number of subjects: 851

Group type: EXPERIMENTAL
Intervention: Accelerated schedule in vaccine-naïve children
Number of subjects: 851
Study: 27343784

Group type: COMPARATOR
Intervention: Placebo (Group P, n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 400mg gabapentin (Group G400, n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 800mg gabapentin (Group G800, n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1200mg gabapentin (Group G1200, n=25)
Number of subjects: 100
Study: 24469705

Group type: EXPERIMENTAL
Intervention: Stemmed prosthesis
Number of subjects: 19

Group type: COMPARATOR
Intervention: Stemless prosthesis
Number of subjects: 19
Study: 22071384

Group type: EXPERIMENTAL
Intervention: BCG-Denmark
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: BCG-Japan
Number of subjects: 164

Group type: COMPARATOR
Intervention: BCG-Russia
Number of subjects: 164
Study: 20609970

Group type: EXPERIMENTAL
Intervention: Prandial Technosphere inhaled insulin plus bedtime insulin glargine
Number of subjects: 677

Group type: COMPARATOR
Intervention: Twice daily premixed biaspart insulin
Number of subjects: 677
Study: 19317948

Group type: EXPERIMENTAL
Intervention: ISA247 0.5 mg/kg/d
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ISA247 1.5 mg/kg/d
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 15578195

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG or Lactobacillus acidophilus CRL431)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (chemically acidified clotted milk without bacteria)
Number of subjects: 64
Study: 11879248

Group type: EXPERIMENTAL
Intervention: Low-flux (LF) hemodialysis for 8 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High-flux (HF) hemodialysis for 8 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined analysis of HF hemodialysis (first 8 weeks of Group Y + second 8 weeks of Group X)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined analysis of LF hemodialysis (first 8 weeks of Group X + second 8 weeks of Group Y)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Analysis of variance for Hct and dialysis membrane permeability
Number of subjects: 25
Study: 10929962

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise
Number of subjects: 59

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 59
Study: 8607952

Group type: EXPERIMENTAL
Intervention: 5 mL of 0.25% bupivacaine hydrochloride infiltrated around each tonsil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Identical placebo (normal saline) infiltration
Number of subjects: 19

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 19
Study: 1333934

Group type: EXPERIMENTAL
Intervention: Sumatriptan (8 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sumatriptan (16 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Morphine (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Morphine (20 mg)
Number of subjects: 12
Study: 6365107

Group type: EXPERIMENTAL
Intervention: Pantethine (300 mg t.i.d.) in type IIB patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pantethine (first treatment) in type IIB patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Pantethine (preceded by placebo) in type IIB patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pantethine (first treatment) in type IV patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Pantethine (preceded by placebo) in type IV patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pantethine in type IV patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Switching from Pantethine to placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pantethine in type IIB patients
Number of subjects: 29
Study: 30794649

Group type: EXPERIMENTAL
Intervention: Women taking oral contraceptives
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Women not taking oral contraceptives
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups of women
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Forced-left cognitive control task
Number of subjects: 45
Study: 29194198

Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod (LBN) 0.024% once daily (qd)
Number of subjects: 840

Group type: COMPARATOR
Intervention: Timolol maleate 0.5% twice daily (bid)
Number of subjects: 840
Study: 26707996

Group type: EXPERIMENTAL
Intervention: Letrozole 10 mg daily for 7 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 25163399

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (VAS)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Oral polio vaccine (OPV0)
Number of subjects: 232
Study: 21801101

Group type: EXPERIMENTAL
Intervention: Autologous whole blood (AWB) injections
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Autologous serum (AS) injections
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 88
Study: 19919597

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Treatment as Usual with Assessment (TAU+)
Number of subjects: 1493
Study: 17362845

Group type: EXPERIMENTAL
Intervention: Sinfrontal
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 15661431

Group type: EXPERIMENTAL
Intervention: Ketamine (60 and 120 ng/mL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 11
Study: 11757473

Group type: EXPERIMENTAL
Intervention: Sustained-release isosorbide-5-mononitrate (IS-5-MN) 100 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9404745

Group type: COMPARATOR
Intervention: Placebo MDI through a 750‐mL cone‐shaped spacer (2 puffs) and nebulized salbutamol aerosol 0.5 mL in 1.5 mL saline solution (group 1, n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Salbutamol MDI and 0.5 mL saline solution in 1.5 mL saline solution (group 2, n=25)
Number of subjects: 50
Study: 8355156

Group type: EXPERIMENTAL
Intervention: 3.5 mm incision with Staar AA‐4203 silicone intraocular lens
Number of subjects: 151

Group type: COMPARATOR
Intervention: 5.5 mm incision with loptex 5 mm x 6 mm oval optic lens
Number of subjects: 151

Group type: COMPARATOR
Intervention: 6.5 mm incision with AMO three‐piece modified C‐loop lens
Number of subjects: 151
Study: 2826548

Group type: EXPERIMENTAL
Intervention: Keyes' method of non‐surgical therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Modified Widman flap surgery
Number of subjects: 9
Study: 2695437

Group type: EXPERIMENTAL
Intervention: Bencyclane
Number of subjects: 19

Group type: COMPARATOR
Intervention: Buflomedil
Number of subjects: 19
Study: 31115309

Group type: EXPERIMENTAL
Intervention: In-depth physician-patient interviews informed by Health Belief Model constructs
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Blood and nasopharyngeal/oralpharyngeal specimens analysis using TaqMan Array Cards for multipathogen detection
Number of subjects: 18
Study: 29340488

Group type: EXPERIMENTAL
Intervention: CPAP10 (CPAP at 10 cmH2O)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CPAP5 (CPAP at 5 cmH2O)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no CPAP)
Number of subjects: 13
Study: 25979532

Group type: EXPERIMENTAL
Intervention: Chest tube removal at drainage volume of less than 300 ml/day (Group B)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Chest tube removal at drainage volume of less than 450 ml/day (Group C)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Chest tube removal at drainage volume of 150 ml/day or less (Group A)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Thoracentesis incidence in Group C
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Reinsertion of chest drains among the three groups
Number of subjects: 168
Study: 24074360

Group type: EXPERIMENTAL
Intervention: DHA 250 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DHA 500 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PNPLA3 M/M genotype
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PNPLA3 I/I genotype
Number of subjects: 60
Study: 21663597

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social skills training (Control)
Number of subjects: 0
Study: 19373239

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 48
Study: 17008338

Group type: EXPERIMENTAL
Intervention: Task-oriented progressive resistance strength training (4 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no rehabilitation training)
Number of subjects: 48
Study: 15564358

Group type: EXPERIMENTAL
Intervention: Social evaluation condition (n = 41)
Number of subjects: 81

Group type: COMPARATOR
Intervention: No social evaluation condition (n = 40)
Number of subjects: 81
Study: 11394950

Group type: EXPERIMENTAL
Intervention: Worksite physical exercise intervention (9 months, supervised, twice a week)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Worksite physical exercise intervention
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 9402118

Group type: EXPERIMENTAL
Intervention: Heater probe
Number of subjects: 81

Group type: COMPARATOR
Intervention: Bipolar probe
Number of subjects: 81
Study: 8354136

Group type: EXPERIMENTAL
Intervention: 250 mg ticlopidine twice daily (group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 300 mg aspirin daily (group 2)
Number of subjects: 24
Study: 3304956

Group type: EXPERIMENTAL
Intervention: Cyclandelate 1600 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flunarizine 10 mg daily
Number of subjects: 40
Study: 31883526

Group type: EXPERIMENTAL
Intervention: 12 weekly sessions of non-specialist-delivered Interpersonal Psychotherapy (IPT)
Number of subjects: 2710

Group type: EXPERIMENTAL
Intervention: 6 months of fluoxetine prescribed by a nurse or clinical officer
Number of subjects: 2710

Group type: EXPERIMENTAL
Intervention: Combination treatment (IPT and fluoxetine)
Number of subjects: 2710

Group type: COMPARATOR
Intervention: IPT
Number of subjects: 2710

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 2710
Study: 28256406

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Partial splenic artery embolisation (PSE)
Number of subjects: 40
Study: 26311640

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 µg every 6 hours for a maximum of 4 doses after 200 mg oral mifepristone
Number of subjects: 625

Group type: COMPARATOR
Intervention: Oral misoprostol 400 µg every 3 hours for a maximum of 4 doses after 200 mg oral mifepristone
Number of subjects: 625
Study: 23498354

Group type: EXPERIMENTAL
Intervention: Supervised dynamic sling training
Number of subjects: 5

Group type: COMPARATOR
Intervention: Traditional unsupervised lumbar stabilization home exercise program (HEP)
Number of subjects: 5
Study: 21375163

Group type: EXPERIMENTAL
Intervention: Conventional phacoemulsification with dual infusion technique through irrigating chopper
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional phaco surgery
Number of subjects: 200
Study: 19687610

Group type: EXPERIMENTAL
Intervention: Comprehensive health education and hot spa bathing, 2-hour program every 2 weeks for 24 weeks, plus individualized programs once a week.
Number of subjects: 43

Group type: COMPARATOR
Intervention: General health guidance (Control group).
Number of subjects: 43